Alterity Therapeutics
ATHE----
H2 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: Alterity Therapeutics(ATHE) the Revenue is 1.161 M (-72.08%), Miss estimate;the EBIT is -10.43 M (-230%), Miss estimate;the EPS is -0.52 (-143.5%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B72.08%
0.00B66.11%
-0.00B5.97%
EBITMiss expectations
-0.01B230.04%
-0.01B183.93%
-0.00B46.11%
EPSMiss expectations
-0.5196143.51%
-0.5067137.45%
-0.01296.06%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf